Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 3, 2025

November 3, 2025

Valor Villages Opens Veterans Housing Facility in St. Louis to Combat Homelessness Among Heroes

EIN Presswire

November 3, 2025

FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease

GlobeNewswire

November 3, 2025

Flo Health and Dr. Sameena Rahman Address Perimenopause and Its Workplace Impact with YourUpdateTV

GlobeNewswire

November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

November 3, 2025

Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

GlobeNewswire

November 3, 2025

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

GlobeNewswire

November 3, 2025

Olema Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire

November 3, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 3, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025

GlobeNewswire

November 3, 2025

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

GlobeNewswire

November 3, 2025

Castle Biosciences Reports Third Quarter 2025 Results

GlobeNewswire

November 3, 2025

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

GlobeNewswire

November 3, 2025

Option Care Health to Participate in Upcoming Investor Conferences

GlobeNewswire

November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire

November 3, 2025

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

GlobeNewswire

November 3, 2025

BBOT to Participate in the Jefferies Global Healthcare Conference in London

GlobeNewswire

November 3, 2025

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire

November 3, 2025

Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions

GlobeNewswire

November 3, 2025

Nyxoah Participera à la Conférence Stifel Healthcare 2025

GlobeNewswire

November 3, 2025

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

GlobeNewswire